Corcept Therapeutics
CORT | NASDAQ
$80.47
-$0.65 (-0.80%)
Nov 2, 2026, 3:42 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 256.15M | 164.9M | 202.13M | 207.64M | 194.43M | 157.21M | 181.89M | 182.55M | 163.8M | 146.81M | 135.41M | 123.6M | 117.72M | 105.65M | 103.06M | 101.73M | 103.39M | 93.69M | 98.82M | 96.13M | 91.59M | 79.44M |
Cost of Revenue | 4.06M | 2.88M | 2.55M | 4.6M | 3.43M | 2.4M | 2.96M | 2.87M | 2.52M | 2.54M | 1.88M | 1.65M | 1.57M | 1.39M | 1.48M | 1.34M | 1.32M | 1.25M | 1.35M | 1.28M | 1.38M | 1.27M |
Gross Profit | 252.09M | 162.02M | 199.58M | 203.04M | 191M | 154.81M | 178.93M | 179.68M | 161.27M | 144.27M | 133.53M | 121.96M | 116.14M | 104.27M | 101.58M | 100.39M | 102.07M | 92.44M | 97.47M | 94.86M | 90.2M | 78.17M |
Operating Income | 41.3M | -49.6M | 4.49M | 10.22M | 26.68M | 3.42M | 25.26M | 46.6M | 35.59M | 29.5M | 31.67M | 31.18M | 29.58M | 14.85M | 22.5M | 31.93M | 31.43M | 26.77M | 36.66M | 36.23M | 31.94M | 19.64M |
Interest Income | n/a | 4.89M | 5.42M | 5.02M | 5.02M | 6.2M | 6.7M | 6.35M | 6M | 5.49M | 5.14M | 5.21M | 3.35M | 3.58M | 1.78M | 1.07M | 630K | 80K | 72K | 72K | 110K | 275K |
Pretax Income | 45.93M | -44.72M | 9.91M | 15.24M | 31.69M | 9.62M | 31.96M | 52.94M | 41.6M | 34.99M | 36.81M | 36.39M | 32.93M | 18.43M | 24.28M | 33M | 32.06M | 26.85M | 36.74M | 36.3M | 32.05M | 19.91M |
Net Income | 42.14M | -31.2M | 24.29M | 19.67M | 35.15M | 20.55M | 30.39M | 46.69M | 35.49M | 27.76M | 31.36M | 31.38M | 27.53M | 15.88M | 16.6M | 34.61M | 27.41M | 22.8M | 32.05M | 30.47M | 26.52M | 23.47M |
Selling & General & Admin | 156.9M | 145.36M | 130.24M | 123.98M | 103.85M | 90.66M | 83.37M | 73.75M | 66.94M | 56.27M | 47.15M | 45.26M | 43.28M | 48.56M | 42.32M | 35.16M | 37.81M | 37.55M | 32.29M | 30.53M | 30.03M | 29.51M |
Research & Development | 53.89M | 66.27M | 64.86M | 68.85M | 60.47M | 60.74M | 70.3M | 59.34M | 58.75M | 58.51M | 54.71M | 45.52M | 43.28M | 40.85M | 36.75M | 33.29M | 32.83M | 28.12M | 28.52M | 28.09M | 28.23M | 29.02M |
Other Expenses | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 210.79M | 211.62M | 195.09M | 192.82M | 164.32M | 151.4M | 153.67M | 133.08M | 125.68M | 114.77M | 101.86M | 90.78M | 86.56M | 89.42M | 79.08M | 68.46M | 70.64M | 65.67M | 60.8M | 58.62M | 58.26M | 58.53M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 214.85M | 214.5M | 197.64M | 197.42M | 167.76M | 153.8M | 156.63M | 135.95M | 128.2M | 117.31M | 103.74M | 92.42M | 88.13M | 90.8M | 80.56M | 69.79M | 71.95M | 66.92M | 62.16M | 59.9M | 59.65M | 59.8M |
Income Tax Expense | -2.94M | -13.51M | -14.38M | -4.43M | -3.46M | -10.93M | 1.21M | 5.73M | 6.11M | 7.23M | 5.45M | 5.01M | 5.4M | 2.56M | 7.68M | -1.6M | 4.65M | 4.05M | 4.68M | 5.83M | 5.53M | -3.55M |
Shares Outstanding (Basic) | 105.38M | 104.44M | 103.7M | 103.55M | 104.11M | 104.11M | 103.64M | 103.37M | 103.12M | 102.79M | 102.46M | 102.01M | 101.96M | 107.89M | 107.7M | 115.17M | 114.16M | 113.99M | 113.74M | 115.79M | 116.29M | 116.82M |
Shares Outstanding (Diluted) | 118.39M | 104.44M | 119.86M | 119.44M | 120.49M | 119.82M | 118.46M | 113.72M | 111.24M | 109.92M | 110.89M | 111.1M | 109.59M | 115.43M | 116.33M | 116.62M | 115.4M | 115.04M | 122.43M | 125.14M | 126.68M | 129.67M |
EPS (Basic) | 0.40 | -0.30 | 0.23 | 0.19 | 0.33 | 0.19 | 0.29 | 0.45 | 0.34 | 0.27 | 0.30 | 0.31 | 0.27 | 0.15 | 0.15 | 0.30 | 0.24 | 0.20 | 0.28 | 0.26 | 0.23 | 0.20 |
EPS (Diluted) | 0.36 | -0.30 | 0.20 | 0.16 | 0.29 | 0.17 | 0.26 | 0.41 | 0.32 | 0.25 | 0.28 | 0.28 | 0.25 | 0.14 | 0.14 | 0.30 | 0.24 | 0.20 | 0.26 | 0.24 | 0.21 | 0.18 |
EBITDA | 46.79M | -44.12M | 10.39M | 15.72M | 32.16M | 10.08M | 32.42M | 53.44M | 41.85M | 35.11M | 37.38M | 36.67M | 33.24M | 18.73M | 25.02M | 33.76M | 32.73M | 27.65M | 37.53M | 37.08M | 32.81M | 20.38M |
EBIT | 45.93M | -44.72M | 9.91M | 15.24M | 31.69M | 9.62M | 31.96M | 52.94M | 41.6M | 34.99M | 36.81M | 36.39M | 32.93M | 18.43M | 24.28M | 33M | 32.06M | 26.85M | 36.74M | 36.3M | 32.05M | 19.64M |
Depreciation & Amortization | 863K | 598K | 482K | 477K | 469K | 462K | 460K | 499K | 257K | 120K | 572K | 289K | 305K | 291K | 747K | 752K | 668K | 802K | 797K | 771K | 756K | 743K |
Add to Watchlist
Select watchlists to add or remove CORT